CORRECTION: Orgenesis Q2 EPS Loss Of $(0.23) Up From $(0.76) YoY, Sales $246.00K Up From $113.00K YoY
Portfolio Pulse from Benzinga Newsdesk
Orgenesis (NASDAQ:ORGS) reported a Q2 EPS loss of $(0.23), an improvement from $(0.76) YoY, and sales of $246K, up from $113K YoY.
August 09, 2024 | 8:35 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Orgenesis reported a significant improvement in its Q2 EPS loss, reducing it to $(0.23) from $(0.76) YoY. Additionally, the company saw a substantial increase in sales, up 117.7% YoY to $246K.
The significant improvement in EPS loss and the substantial increase in sales are positive indicators for Orgenesis. Investors may view these results favorably, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100